FDA
-
-
-
-
-
-
-
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
-
-
-
-
-
-
-
Axonics, Inc. (AXNX) Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
-
-
-
-
-
-
-
BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors
-
-
-
-
-
-
-
Axonics, Inc. (AXNX) Reports Prelim FY22 Revenue of $273.6M, Guides FY23 Revenue of $342M
-
-
-
-
-
-
-
Nyxoah Nominates Raymond Cohen and Virginia Kirby for Appointment to Its Board of Directors
-
-
-
-
-
-
-
Axonics® Reports Second Quarter 2021 Financial Results
-
-
-
-
-
-
-
Lyra Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update
-
322,203 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

